bristol-myers squibb global reporting initiative content index · bristol-myers squibb global...

14
March 2016 Bristol-Myers Squibb Global Reporting Initiative Content Index Bristol-Myers Squibb reports in alignment with the Global Reporting Initiative’s 2013 G4 Sustainability Reporting Guidelines at the Core level. The following index facilitates access to Core reporting elements as well as additional Comprehensive level elements where available. For each G4 performance indicator below, we include a link to the pertinent section of the Bristol-Myers Squibb website or provide a specific response directly. We are interested in your feedback. Please send us your comments on the GRI Content Index below. GRI G4 Indicator Reporting Level Description Source on bms.com Response Level (F=Full; P=Partial) General Standard Disclosures Strategy and Analysis G4-1 Core Statement from senior management CEO Message F G4-2 Comp Description of key impacts, risks, opportunities Sustainability Issues F Organizational Profile G4-3 Core Name of the organization Key Facts F G4-4 Core Primary brands, products and services Key Facts F G4-5 Core Location of organization’s headquarters New York, New York, USA F G4-6 Core Number and name of countries where the organization operates Economic Responsibility Economic Performance Facility Information F G4-7 Core Nature of ownership and legal form Key Facts Economic Responsibility F G4-8 Core Nature of markets served (including geographic breakdown, sectors served, and types of customers and beneficiaries) Economic Responsibility Economic Performance F G4-9 Core Scale of the reporting organization (employees, operations, net sales, capitalization, quantity of products/services) Key Facts Economic Performance Key Performance Indicators 2014 Annual Report, page 29 F G4-10 Core Total workforce by employment type, employment contract, and region, broken down by gender, report significant variations in employment numbers Diversity and Work/Life Integration Key Indicators P - Total global workforce headcount is provided. Gender and minority breakdown by employment level is currently available for the U.S.

Upload: voliem

Post on 25-Apr-2018

228 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

Bristol-Myers Squibb Global Reporting Initiative Content Index Bristol-Myers Squibb reports in alignment with the Global Reporting Initiative’s 2013 G4 Sustainability Reporting Guidelines at the Core level. The following index facilitates access to Core reporting elements as well as additional Comprehensive level elements where available. For each G4 performance indicator below, we include a link to the pertinent section of the Bristol-Myers Squibb website or provide a specific response directly. We are interested in your feedback. Please send us your comments on the GRI Content Index below.

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

General Standard Disclosures Strategy and Analysis G4-1 Core Statement from senior management CEO Message F G4-2 Comp Description of key impacts, risks,

opportunities Sustainability Issues F

Organizational Profile G4-3 Core Name of the organization Key Facts F G4-4 Core Primary brands, products and services Key Facts F G4-5 Core Location of organization’s headquarters New York, New York, USA F G4-6 Core Number and name of countries where

the organization operates Economic Responsibility Economic Performance Facility Information

F

G4-7 Core Nature of ownership and legal form Key Facts Economic Responsibility

F

G4-8 Core Nature of markets served (including geographic breakdown, sectors served, and types of customers and beneficiaries)

Economic Responsibility Economic Performance

F

G4-9 Core Scale of the reporting organization (employees, operations, net sales, capitalization, quantity of products/services)

Key Facts Economic Performance Key Performance Indicators 2014 Annual Report, page 29

F

G4-10 Core Total workforce by employment type, employment contract, and region, broken down by gender, report significant variations in employment numbers

Diversity and Work/Life Integration Key Indicators

P - Total global workforce headcount is provided. Gender and minority breakdown by employment level is currently available for the U.S.

Page 2: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial) workforce only.

G4-11 Core Percentage of total employees covered by collective bargaining agreements

Not Reported N – Information is not collected globally

G4-12 Core Describe supply chain CDP Supplier Diversity Standards of Business Conduct and Ethics, Third Party Sustainability 2015 Goals: Mid-Term Progress Report Our Suppliers

F

G4-13 Core Significant changes from previous report regarding size, structure, ownership, or its supply chain

A Brief History of Bristol-Myers Squibb

F

Commitments to External Initiatives G4-14 Core Explanation of whether and how the

precautionary approach or principle is addressed by the organization

Systems for Managing Risk Third Party Standards United Nations Universal Declaration

F

G4-15 Core External charters, principles, initiatives Overarching Policies– Voluntary standards

F

G4-16 Core Memberships in associations Stakeholder Engagement– Business association memberships

F

Identified Material Aspects and Boundaries G4-17 Core Entities included in financial

statements, and specify which are included/excluded from this report

Key Facts Our Partners Leadership 2014 Annual Report, page 33

F

G4-18 Core Process for defining report content and aspect boundaries, explain implementation of Reporting Principles for Defining Report Content

About this Report– Reporting Period and Scope Sustainability Issues Stakeholder Engagement

F

G4-19 Core List all material Aspects identified in the process for defining report content

Materiality Assessment F

G4-20 Core Boundary of the report within the organization, is Aspect material within the organization, and specific limitations

About this Report– Reporting Period and Scope

F

G4-21 Core Boundary of the report outside the organization, is Aspect material outside the organization, and specific limitations

About this Report– Reporting Period and Scope

F

Page 3: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

G4-22 Core Explanation of the effect of any restatements of information provided in previous reports

About this Report– Reporting Period and Scope Transportation

F

G4-23 Core Significant changes from previous reporting periods in the Scope and Aspect Boundaries

About this Report– Reporting Period and Scope

F

Stakeholder Engagement G4-24 Core List of stakeholder groups engaged by

the organization Stakeholder Engagement World Health Organization Access to Medicines UN Global Compact Pharmaceutical Supply Chain Initiative Together on Diabetes What We Support Grants & Giving Drug Donations and Other Philanthropic Efforts Disaster Relief & Product Donations Bristol-Myers Squibb Foundation Reducing Health Disparities Cancer in Europe Our Partners Political Contributions Investor Relations Our Communities Worldwide Facilities Workplace Policies Materiality Assessment

F

G4-25 Core Basis for identification and selection of stakeholders with whom to engage

Stakeholder Engagement Partnering Areas of Interest Our Process Our Partners How to Apply for Bristol-Myers Squibb Foundation Grants Political Contributions Clinical Research Grants Corporate Giving Independent Medical Education

F

G4-26 Core Approaches to stakeholder engagement, including frequency of engagement by type and by stakeholder group

Stakeholder Engagement F

G4-27 Core Key topics and concerns that have been raised through stakeholder engagement,

Position on Key Issues Stakeholder Engagement

F

Page 4: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

and how the organization has responded to those key topics and concerns. Report stakeholder groups that raised each key topic and concern.

Materiality Assessment

Report Profile G4-28 Core Reporting period About this Report– Reporting

Period and Scope F

G4-29 Core Date of most recent previous report About this Report– Reporting Period and Scope

F

G4-30 Core Reporting cycle About this Report– Reporting Period and Scope

F

G4-31 Core Contact information Feedback on Sustainability Contact Us

F

GRI Content Index G4-32 Core "In accordance" option and location of

the GRI content index We are reporting in accordance with the Global Reporting Initiative's (GRI) G4 guidelines at the "Core" level. This report also contains supplemental Standard Disclosures from the GRI Sustainability Reporting guidelines. GRI Index About this GRI Report

F

Assurance G4-33 Core Assurance About this Report

Verification F

Governance Governance Structure and Composition G4-34 Core Governance structure of the

organization, including committees under the highest governance body. Identify any committees responsible for decision-making on economic, environmental and social impacts.

Corporate Governance Board of Directors Committee Charters

F

G4-35 Comp Process for delegating authority for economic, environmental and social topics from highest governance body to senior executives and other employees.

Our Commitment to Responsibility Principles of Integrity: BMS Standards of Business Conduct and Ethics

F

G4-36 Comp Identify executive-level position with responsibility for economic, environmental and social topics and reporting to highest governance body.

Accountability and Organization F

G4-37 Comp Mechanisms for consultation between stakeholders and highest governance

Codes of Conduct Third Party Standards Contact Our Directors

F

Page 5: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

body on economic, environmental and social topics

Dialogue

G4-38 Comp Composition of the highest governance body and its committees

Corporate Governance Guidelines Corporate Governance – Board of Directors

F

G4-39 Comp Indicate whether the Chair of the highest governance body is also an executive officer, and if so, reason for this arrangement.

Key Facts Corporate Governance Guidelines Corporate Governance – Organization Board of Directors

F

G4-40 Comp Report the nomination and selection processes for the highest governance body and its committees, and the criteria used for nominating and selecting highest governance body members

Corporate Governance Guidelines – Composition and Structure of the Board Committee on Directors and Corporate Governance

F

G4-41 Comp Processes in place for the highest governance body to ensure conflicts of interest are avoided and managed

Corporate Governance Guidelines

F

Highest Governance Body’s Role in Setting Purpose, Values and Strategy G4-42 Comp Role of highest governance body and

senior executives in developing, approving, and updating the purpose, value, or mission statements, strategies, policies and goals related to economic, environmental and social impacts.

Sustainability 2015 Goals – Mid-Term Progress Report Our Mission & Commitment EHS Policy Sustainability 2015 Goals Corporate Governance Guidelines EHS Management System Integration

F

Highest Governance Body’s Competencies and Performance Evaluation G4-43 Comp Measures taken to develop and enhance

the highest governance body's collective knowledge of economic, environmental and social topics

Sustainability 2015 Goals Corporate Governance Guidelines EHS Management System Integration

F

G4-44 Comp Process for evaluating the highest governance body's own performance with respect to economic, environmental and social and if evaluation is independent or self-assessment

Corporate Governance Guidelines – Evaluating the Board’s Performance Committee on Directors and Corporate Governance Charter EHS Management System Integration – Accountability and Organization

F

Highest Governance Body’s Role in Risk Management

Page 6: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

G4-45 Comp Process of the highest governance body's role for overseeing the organization's identification and management of economic, environmental, and social performance and if stakeholder consultation is used

Corporate Governance - Organization Management Systems Third Party Standards

F

G4-46 Comp Role of the highest governance body in reviewing the effectiveness of the organization's risk management processes for EES topics

Sustainability 2015 Goals – Mid-Term Progress Report Sustainability 2015 Goals Sustainability 2020 Goals Accountability and Organization

F

G4-47 Comp Frequency of the highest governance body's review of EES impacts, risks, and opportunities

Sustainability 2015 Goals – Mid-Term Progress Report Sustainability 2015 Goals Sustainability 2020 Goals Accountability and Organization

F

Highest Governance Body’s Role in Sustainability Reporting G4-48 Comp Highest committee or position that

formally reviews and approves the organization's sustainability report and ensures all material Aspects are covered

Accountability and Organization F

Highest Governance Body’s Role in Evaluating Economic, Environmental and Social Performance G4-49 Comp Process for communicating critical

concerns to the highest governance body

Accountability and Organization F

G4-50 Comp Nature and total number of critical concerns that were communicated to the highest governance body and the mechanism(s) used to address and resolve them

Materiality Assessment Corporate Governance Guidelines Committee on Directors and Corporate Governance Charter Systems for Managing Risks EHS Management System Integration

P

Remuneration and Incentives G4-51 Comp Remuneration policies for highest

governance body and senior executives; linkage between compensation for members of the highest governance body, senior managers, and executives, and the organization's performance

Corporate Governance Guidelines Corporate Governance – Compensation and Non-Financial Goals Compensation and Management Development Committee Charter

F

G4-52 Comp Process for determining remuneration. Corporate Governance Guidelines

F

Page 7: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

Corporate Governance – Compensation and Non-Financial Goals Compensation and Management Development Committee Charter

Ethics and Integrity G4-56 Core Internally developed statements of

mission or values, codes of conduct, codes of ethics, and principles relevant to sustainable development

Codes of Conduct Our Mission & Commitment Standards of Business Conduct and Ethics, Third Party

F

G4-57 Comp Internal and external mechanisms for seeking advice on ethical and lawful behavior, and matters related to organizational integrity, such as helplines or advice lines.

Codes of Conduct Standards of Business Conduct and Ethics, Third Party Contact Us

F

G4-58 Comp Internal and external mechanisms for reporting concerns about unethical or unlawful behavior, and matters related to organizational integrity, such as escalation through line management, whistleblowing mechanisms or hotlines.

Codes of Conduct Standards of Business Conduct and Ethics, Third Party Contact Us

F

Specific Standard Disclosures Disclosures on Management Approach G4-DMA Core Category: Economic Aspect: Economic Performance G4-EC1 Core Direct economic value generated and

distributed, including revenues, operating costs, employee compensation, donations and other community investments, retained earnings, and payments to capital providers and governments

Our Company Research and Development 2014 Annual Report, (Results of Operations, pages 7-9; Consolidated Financial Statements, pages 29-31) 2014 Annual Report, (Fair Value Measurement, page 56) 2014 Annual Report, (Accrued Employee Compensation and Benefits, page 62) 2014 Annual Report, (Dividends, page 17) 2014 Annual Report, (Interest, pages 14, 20) 2014 Annual Report, (Charge-backs related to government programs, pages 8-9, 22) Our Corporate Responsibility, pages 22-23

F

Page 8: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

Grants & Giving Economic Performance Key Performance Indicators Benefits Shareholder Value

G4-EC2 Financial implications and other risks and opportunities for the organization's activities due to climate change

Material issues –Energy and Water Risk/Opportunity related to Climate Change CDP

F

G4-EC3 Coverage of the organization's defined benefit plan obligations

2014 Annual Report, (Pension, Postretirement and Postemployment Liabilities, pages 65-67)

F

Aspect: Indirect Economic Impacts G4-EC7 Development and impact of

infrastructure investments and services supported

Bristol-Myers Squibb Foundation

F

G4-EC8 Significant indirect economic impacts, including the extent of impacts

Indirect Benefits F

Category: Environmental Aspect: Materials G4-EN2 Percentage of materials used that are

recycled input materials Product Stewardship – Eco-Efficiency

P

Aspect: Energy G4-EN3 Core Direct energy consumption by primary

energy source including coal, natural gas, distilled fuel, biofuels, ethanol, hydrogen. The indicator covers scope 1 of the WRI/WBCSD GHG Protocol. Report total direct energy consumption in joules or multiples by renewable/non-renewable primary source.

Energy Conservation Energy Star Award Sustainability Issues Energy and Water Key Performance Indicators EPA Sustainability 2015 Goals Sustainability 2020 Goals

F

G4-EN4 Energy consumption outside of the organization

Goals and Key Indicators - Business Air Travel

P

G4-EN5 Energy intensity Goals and Key Indicators F G4-EN6 Reduction of energy consumption Energy Conservation

Sustainability Issues Energy and Water Energy Star Award Sustainability 2015 Goals Sustainability 2020 Goals

F

Aspect: Water G4-EN8 Core Total water withdrawal by source Water Use

Sustainability Issues Energy and Water Key Performance Indicators

F – Total water withdrawal is provided with

Page 9: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

Sustainability 2015 Goals Sustainability 2020 Goals

list of source types.

G4-EN9 Water sources significantly affected by withdrawal of water

Water Use F

G4-EN10 Percentage and total volume of water recycled and reused

Water Use Key Performance Indicators Sustainability 2015 Goals Beneficial Reuse is available in our Operating Report. Water Use is provided in the Carbon Disclosure Project’s Water Disclosure initiative.

F - Water reuse at Hopewell represents 0.1% of total water withdrawal companywide.

Aspect: Biodiversity G4-EN13 Habitats protected or restored Biodiversity and Land Use

Plainsboro Facility Page Princeton Facility Page Wallingford Facility Page Devens Facility Page

F

G4-EN14 Number of IUCN Red List species and national conservation list species with habitats in areas affected by operations, by level of extinction risk

Biodiversity and Land Use F

Aspect: Emissions G4-EN15 Core Direct greenhouse gas emissions (Scope

1) Climate Change and Greenhouse Gas Emissions Key Performance Indicators Sustainability 2015 Goals Sustainability 2020 Goals

F

G4-EN16 Indirect greenhouse gas emissions (Scope 2)

Climate Change and Greenhouse Gas Emissions Key Performance Indicators

F

G4-EN17 Other relevant indirect greenhouse gas emissions (Scope 3)

Climate Change and Greenhouse Gas Emissions Key Performance Indicators

P

G4-EN18 GHG Emissions intensity Climate Change and Greenhouse Gas Emissions

F

G4-EN19 Reduction of greenhouse gas emissions Climate Change and Greenhouse Gas Emissions Energy Conservation

F

G4-EN20 Emissions of ozone-depleting substances (ODS)

Other Air Emissions F

G4-EN21 NOx, SOx, and other significant air emissions by type

Other Air Emissions F (NOx and SOx are not considered significant emissions

Page 10: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial) from our facilities)

Aspect: Effluents and Waste G4-EN22 Total water discharge by quality and

destination Wastewater Effluents P

G4-EN23 Total weight of waste by type and disposal method

Waste Key Performance Indicators

P

G4-EN24 Core Total number and volume of significant spills

Compliance and Remediation F

G4-EN25 Weight of transported, imported, exported, or treated waste deemed hazardous under the terms of the Basel Convention Annex I, II, III, and VIII, and percentage of transported waste shipped internationally

Goals and Key Indicators F

Aspect: Products and Services G4-EN27 Core Initiatives to mitigate environmental

impacts of products and services, and extent of impact mitigation

Product Stewardship Wastewater Effluents

F

Aspect: Compliance G4-EN29 Monetary value of significant fines and

total number of non-monetary sanctions for non-compliance with environmental laws and regulations

Compliance and Remediation F

Aspect: Transport G4-EN30 Significant environmental impacts of

transporting products and other goods and materials used for the organization's operations, and transporting members of the workforce

Transportation P

Aspect: Supplier Environmental Assessment G4-EN32 Core Percentage of new suppliers that were

screened using environmental criteria Our Suppliers Standards of Business Conduct and Ethics for Third Parties

F

Category: Social Sub-Category: Labor Practices and Decent Work Aspect: Employment G4-LA2 Core Benefits to full time employees Benefits Program Highlights,

Wages and Benefits F

Aspect: Occupational Health and Safety G4-LA5 Percentage of total workforce

represented in formal joint management-worker health and safety committees that help monitor and advise on occupational health and safety programs

Safety – Safety Committees P

Page 11: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

G4-LA6 Core Types of injury and rates of injury, occupational diseases, lost days, and absenteeism, and total number of work-related fatalities by region and by gender

Safety Goals & Key Indicators Sustainability 2015 Goals Sustainability 2020 Goals

P - Recordable case rates, days away from work case rates and fatalities are currently reported companywide. Reporting is aligned with U.S. OSHA reporting regulations. Reporting on absenteeism and breakdowns by region and gender are not available at this time.

Aspect: Training and Education G4-LA10 Core Programs for skills management and

lifelong learning that support continued employability of employees and assist them in managing career endings.

Benefits Listing Developing our People Education and Training Sustainability 2020 Goals

F

Aspect: Diversity and Equal Opportunity G4-LA12 Core Composition of governance bodies and

employee breakdown per employee category by gender, age, minority group member (other diversity)

Board of Directors Diversity and Inclusion Workforce Statistics Our Suppliers Workplace Policies Supplier Diversity Intellectual Property Our Culture

P - Gender and minority breakdowns are provided for our Board of Directors and U.S. workforce. Age breakdowns are not available at this time.

Sub-Category: Human Rights Aspect: Investment G4-HR1 Total and Percentage of investment

agreements and contracts that include human rights clauses

Standards of Business Conduct and Ethics for Third Parties

P

Aspect: Child Labor

Page 12: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

G4-HR5 Child labor incidents and measures to eliminate child labor

Workplace Policies - Labor Standards of Business Conduct and Ethics for Third Parties, page 3 Bristol-Myers Squibb UN Global Compact Communication on Progress 2015

P

Aspect: Forced or Compulsory Labor G4-HR6 Forced labor incidents and measures to

eliminate forced labor Workplace Policies - Labor Our Communities Overarching Policies Social Progress Principles of Integrity: BMS Standards of Business Conduct and Ethics

P

Aspect: Security Practices G4-HR7 Security personnel trained to understand

human rights Workplace Policies - Security F

Aspect: Assessment G4-HR9 Percentage and total number of

operations that have been subject to human rights reviews and/or impact assessments

Bristol-Myers Squibb UN Global Compact Communication on Progress 2015

P

Aspect: Supplier Human Rights Assessment G4-HR10 Percentage of new suppliers that were

screened using human rights criteria Pharmaceutical Supply Chain Initiative Bristol-Myers Squibb UN Global Compact Communication on Progress 2015 Standards of Business Conduct and Ethics for Third Parties

P

Sub-Category: Society Aspect: Anti-corruption G4-SO4 Core Percentage of employees trained in anti-

corruption policies/procedures Compliance & Ethics – All employees must read and sign off on the Principles of Integrity: BMS Standards of Business Conduct and Ethics as a condition of employment.

F

Aspect: Public Policy G4-SO6 Total value of financial and in-kind

contributions to political parties, politicians, and related institutions by country

Political Contributions

P

Aspect: Compliance

Page 13: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016

GRI G4 Indicator

Reporting Level Description Source on bms.com

Response Level (F=Full; P=Partial)

G4-SO8 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with laws and regulations

SEC Filings EHS Compliance & Remediation Product Responsibility 2014 Annual Report, page 71 Principles of Integrity: BMS Standards of Business Conduct and Ethics, Data Privacy, page 7

F

Aspect: Supplier Assessment for Impacts on Society G4-SO9 Percentage of new suppliers that were

screened using criteria for impacts on society

Standards of Business Conduct and Ethics, Third Party Our Suppliers Supplier Diversity CDP Supply Chain

P

Sub-Category: Product Responsibility Aspect: Customer Health and Safety G4-PR1 Percentage of significant product and

service categories for which health and safety impacts are assessed for improvement.

Sustainability 2015 Goals Sharps Management Plan Product Stewardship Wastewater Effluents - Toxicology Sustainability 2020 Goals

P

G4-PR2 Total number of incidents of non-compliance with regulations and voluntary codes concerning health and safety impacts of products and services during their life cycle, by type of outcomes

Clinical Trials Disclosure Clinical Trials

P

Aspect: Product and Service Labeling G4-PR3 Type of product and service information

required by procedures, and percentage of significant products and services subject to such information requirements

Products P

Aspect: Marketing Communications G4-PR7 Total number of incidents of non-

compliance with regulations and voluntary codes concerning marketing communications, including advertising, promotion, and sponsorship by type of outcomes

2014 Annual Report - General Commercial Litigation, pp 72-73

P

Aspect: Compliance G4-PR9 Core Monetary value of significant fines for

non-compliance with laws and regulations concerning the provision and use of products and services

2014 Annual Report, Page 71 F

Page 14: Bristol-Myers Squibb Global Reporting Initiative Content Index · Bristol-Myers Squibb Global Reporting Initiative Content Index . Bristol-Myers Squibb ... we include a link to the

March 2016